The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2020

Filed:

Feb. 01, 2017
Applicant:

Stc.unm, Albuquerque, NM (US);

Inventors:

Pamela Hall, Albuquerque, NM (US);

Bryce Chackerian, Albuquerque, NM (US);

David S. Peabody, Albuquerque, NM (US);

Seth Michael Daly, Albuquerque, NM (US);

Bradley Owen Elmore, Worthington, MN (US);

Kathleen Triplett, Albuquerque, NM (US);

Assignee:

UNM Rainforest Innovations, Albuquerque, NM (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); A61K 39/085 (2006.01); A61P 37/04 (2006.01); A61P 31/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/085 (2013.01); A61P 31/04 (2018.01); A61P 37/04 (2018.01); A61K 2039/52 (2013.01); A61K 2039/5258 (2013.01); C12N 2795/18123 (2013.01);
Abstract

The present invention is directed to virus-like particles (VLPs) which are engineered to present epitopes from(SA), preferably autoinducing peptides (AIPs) which regulate quorum-sensing dependent virulence in this pathogen, or epitopes from SA toxins and leukocidins. These VLPs may be used to provide immunogenic compositions and efficacious vaccines. In a mouse model of SA dermonecrosis, vaccination with AIP-containing VLPs or SA toxin-containing VLPs induces protective immunity to limit the pathogenesis of SA infection and promote bacterial clearance.


Find Patent Forward Citations

Loading…